|
Market Closed -
Euronext Paris
23:55:00 25/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 143.30 EUR | -3.89% |
|
-8.08% | +20.42% |
| 09-26 | US FDA approves Mirum's drug for rare bone disorder | RE |
| 09-22 | European Pharma Leaders Push for National Reforms to Boost Investment | DJ |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 165.4 | +15.42% | 15 | ||||||
| 1,325.39 | +11.99% | 29 | ||||||
| 277.91 | +2.47% | 22 | ||||||
| 278.61 | +5.4% | 28 | ||||||
| 375.34 | +4.17% | 19 | ||||||
| 152.43 | +5.45% | 22 | ||||||
| 211.41 | +27.21% | 23 | ||||||
| 389.22 | -6.12% | 29 | ||||||
| 158.65 | +5.12% | 26 | ||||||
| 307.56 | +21.56% | 23 | ||||||
| 28.88 | +0.72% | 26 | ||||||
| 570.32 | +8.39% | 28 | ||||||
| 66.71 | +6.12% | 24 | ||||||
| 21.75 | +17.49% | 21 | ||||||
| 94.06 | +31.02% | 24 | ||||||
| 9,183.33 | +38.8% | 15 | ||||||
| 6,622.06 | +10.94% | 16 | ||||||
| 58.22 | +16.4% | 18 | ||||||
| 71.35 | +59.06% | 17 | ||||||
| Average | 1,071.51 | +14.82% | 22 | ||||||
| Weighted average by Cap. | 722.21 | +9.74% | 25 |
- Stock Market
- Stocks
- IPN Stock
- Sector Ipsen
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
